Skip to main content
. 2017 Jul 28;7(9):e00776. doi: 10.1002/brb3.776

Table 3.

Percentage of clinical groups with <2 and >2 pathological biomarkers

<2 Biomarkers ≥2 Biomarkers
aMCI 52.8% 47.2%
naMCI 74.1% 25.9%
SCD 76.5% 23.5%

SCD, subjective cognitive decline.